SYNTEKABIO, INC.
Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.
SYNTEKABIO, INC.
Social Links:
Industry:
Biotechnology Health Care Medical Service Industry
Founded:
2009-10-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.syntekabio.com
Total Employee:
1+
Status:
Active
Total Funding:
877 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag
Current Employees Featured
Founder
Investors List
Altos Ventures
Altos Ventures investment in Venture Round - Syntekabio, Inc.
Official Site Inspections
http://www.syntekabio.com
- Host name: ec2-3-145-204-67.us-east-2.compute.amazonaws.com
- IP address: 3.145.204.67
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Syntekabio, Inc." on Search Engine
Syntekabio
About Us. Syntekabio is an AI new drug development company. based on genomic big data. Business Area. Syntekabio derives new drug candidates through DeepMatcher®, …See details»
Syntekabio - Crunchbase Company Profile & Funding
Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data. Daejeon, Taejon-jikhalsi, South …See details»
Syntekabio
Syntekabio is an AI new drug development company. based on genomic big data. Who We Are. Drug discovery and development company bringing together biology and AI/ML …See details»
Syntekabio
Syntekabio is an AI new drug development company based on genomic big data. We are Syntekan. Introducing the global Synteka team with bio analysis technology. AI Drug …See details»
Syntekabio Inc. | LinkedIn
Founded. 2009. Specialties. Biotechnology, Bioinformatics, AI Drug Discovery, Cloud Platform, Drug Development, Small Molecules, Proteins, Peptides, Cells, Gene …See details»
Syntekabio - Funding, Financials, Valuation & Investors
Funding. Syntekabio has raised a total of. $211.5M. in funding over 6 rounds. Their latest funding was raised on Apr 3, 2024 from a Post-IPO Equity round. Syntekabio is …See details»
Syntekabio to Showcase Innovative AI Drug Discovery
Apr 11, 2024 Dr. Kruzel will present Syntekabio’s disease-agnostic approach to AI-driven drug discovery that yields viable drug candidates. Bringing together biology, AI, and …See details»
Syntekabio - Updates, News, Events, Signals & Triggers
Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.See details»
Syntekabio - Company info. interviews, news
Founded. 2009. Patents. 10. Publications. 14. Technologies. AI Companies (Drug Discovery) Syntekabio is a leading AI-driven drug discovery company that uses machine learning and supercomputing to discover new drugs. …See details»
Syntekabio - Products, Competitors, Financials, …
Overview & Products. Financials. Alternatives & Competitors. Founded Year. 2009. Stage. PIPE | IPO. Total Raised. $33.2M. About Syntekabio. Syntekabio helps in the …See details»
Syntekabio
Syntekabio Developing new Drug Discovery paradigm utilizing AI and Gemomic Big Data ...See details»
Syntekabio to Showcase Innovative AI Drug Discovery …
Apr 11, 2024 Syntekabio Co., Ltd. (KOSDAQ: 226330) is a drug discovery company bringing together biology and AI/ML since 2009 and facilitating the discovery of first-in …See details»
Syntekabio to Showcase Advanced AI Drug Discovery …
May 23, 2024 Syntekabio Co., Ltd. (KOSDAQ: 226330) is a drug discovery company bringing together biology and AI/ML since 2009 and facilitating the discovery of first-in …See details»
Syntekabio to Showcase Biologics Discovery Platform at PEGS …
May 7, 2024 Company offering discovery services for neoantigens with Neo-ARS and for full antibodies with Ab-ARSNEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- …See details»
Press Release Distribution and Management - GlobeNewswire
Apr 11, 2024 NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced …See details»
Syntekabio
Discovery & Development. This is the one-stop service DDC (DeepMatcher® Drug Candidate) based on the 'DeepMatcher®' technology. This service, starting from AI …See details»
Prescient Growth Ideas Emerge From the Fringe - Inc.com
12 hours ago Unlike an organization's elites, outsiders are not socialized to defend the status quo. Goldberg's team found compelling evidence that prescient ideas come from …See details»
Access to affordable housing should be universal, report …
1 day ago National Housing Council report warns Canada lags behind Organization for Economic Co-operation and Development peers in spending on non-market housingSee details»
Get In Touch – PATH Foundation
We’ll get back to you right away. Please note – if you are interested in grant opportunities, our organization currently supports efforts serving Fauquier, Rappahannock and …See details»
Syntekabio - Contacts, Employees, Board Members, Advisors
Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.See details»